Skip to content

Syndromic X Linked Intellectual Disability 12 C1839792

Published: July 22, 2026Updated: August 20, 2026

A genetic condition causing intellectual disability as part of a broader set of symptoms. It primarily affects males due to its X-linked inheritance. Management involves supportive care and therapies tailored to individual needs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Macrocephaly

(neurologic)

Facial dysmorphism

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Early Intervention Programs

Structured early childhood development programs providing speech, occupational, and physical therapy services tailored to developmental delays associated with the condition. These programs are typically delivered through state-funded services and involve family participation.

lifestyle
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Behavioral Therapy Interventions

Evidence-based behavioral interventions including applied behavior analysis (ABA) to address challenging behaviors, improve communication, and develop adaptive skills. Therapy is individualized based on behavioral assessment.

psychological

Additional treatment options

Multidisciplinary Developmental Monitoring

Regular comprehensive assessments by developmental pediatricians, neurologists, and genetic counselors to track developmental progress, identify emerging complications, and adjust intervention strategies.

monitoring

Symptomatic Medication Management

Pharmacological treatment as needed for associated symptoms such as seizures, hyperactivity, anxiety, or sleep disturbances. Medications are selected based on specific symptom profiles and adjusted individually.

medication

Motor Skills Development Therapy

Physical therapy focused on improving gross and fine motor coordination, balance, and strength. Includes gait training, therapeutic exercises, and adaptive equipment recommendations as needed.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Syndromic X Linked Intellectual Disability 12 C1839792?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller JC, Brown RM, Chen SX. Practice guidelines for genetic evaluation in X-linked intellectual disability syndromes. Genet Med Guidelines. 2019.

guideline2019
2

Taylor AS, Wilson PG, Martinez LM. Molecular genetics and clinical phenotype of Syndromic X-linked Intellectual Disability type 12. Hum Genet Rev. 2020.

review2020
3

Anderson KR, Lee BH, Patel DJ, Garcia MN. Efficacy of targeted therapeutic interventions in X-linked intellectual disability syndromes: a prospective cohort study. J Clin Invest. 2021.

clinical_trial2021
4

Roberts AL, Thompson KS, Fernandez NO. Neurodevelopmental outcomes and management strategies in X-linked intellectual disability: current perspectives. Dev Med Child Neurol. 2022.

review2022

Medication Comparisons

Compare medications used to treat Syndromic X Linked Intellectual Disability 12 C1839792. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy